Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by Interpolation1on Aug 08, 2016 9:41am
340 Views
Post# 25118934

RE:Bought at $1

RE:Bought at $11)  Gloating is never good ... "bought at $1".   Most of us bought low, sold high, bought back at the new low etc ... I know several icluding myself with an effective share price under $0.30 doing that several times since November.    I own some some companies where my own SP is effectively "negative" doing that.  Anyone who bought the big four at anytime in 2016 is up money ...  and well above the TSX index and with new 52 week highs crushed ... bought anytime period!

2)  It won't fall far below $2.00 ... it will not fall below $2.00 period.

3)  2018 Price target?  Why?  $30M just raised and there will be M&A activity.  APH needs a partner .... snail pace client growth lately. Google the Harvard CONSOLIDATION CURVE (also in the June issue of CannaInvestor) as it is a simple truth that cannot be avoided.   No marketing (vs Tweed and Metttrum).  Yes advertising is prohibited but Tweed has name recognition and Mettrum's hemp products are on shelves plus the maming rights of the "grass" area (of course) at the Amplitheatre.  Vic himself told me at the expo he expect legalization of recreational to be later 2018 rather than earlier and possibly early 2019.  One cannot predict or project SP at this time.   Just hang on for the ride.

Not dissing your post ... not my intent ... just way too many variables at play.  The real point to my #1 above is that when everyone starts to brag that is generally a SELL signal .... history proves it to be true.

CannaInvestor Magazine had CGC, APH, and OGI as case studies well before all three's recent stock increas runs ... it is free to subscribe to so a great read and nice to see it before the SP increases rather than the usual "afterwards" with the "as predicted" comments we see all too often.  Plus it has Canadian Content and their webinar series are great ... CEOs of companies etc etc ... all free!  


Alexeiv wrote:
My concern with Aphria has been long-term investors. Like back in November of 2015, the pot stocks spiked and subsided when the dat traders were gone. At such a high increase over 2 weeks I feel it's a good time to sell if you bought this way below $2.00

It won't fall far below $2.00 even in the event of a crash (pot stocks should not be affected much by market correction). However for those like me who didn't put too much and are looking at 150%. I think it's a reasonable time to sell.

Fact is, this is more emotion than logic at the moment. The future? Probably 10-14$ but that's 2018.


Bullboard Posts